NVO Stock Slips 4% as Roche Inks Obesity Drug Deal With Zealand
With Roche's latest deal, a new contender enters the obesity space, which could threaten NVO and LLY's dominance in the ...
How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma
Given the optimism around its obesity candidate, we believe investors should stay invested in Viking Therapeutics.
Tax Guru9h
No section 271C penalty for mere delay in TDS remittance: ITAT Ahmedabad
Year 2015-16 and 2016-17 with the issues involved relating to levy of penalty under section 272A(2)(g) and section 271C of the Income Tax Act, 1961 (“the Act” for short). All the appeals arise from ...
UAE Moments on MSN14h
10 Valuable Inventions Made in the Philippines
The Philippines is not only known for its stunning landscapes and warm-hearted people but also for its brilliant minds that ...
Zacks Investment Research on MSN19h
Nektar Q4 Loss Wider Than Expected, Pipeline in Focus, Stock Up
Nektar Therapeutics NKTR incurred an adjusted loss per share of 15 cents in the fourth quarter of 2024, wider than the Zacks ...